Quantification of HLA class I molecules on renal cell carcinoma using Edman degradation

BACKGROUND: Unimpaired HLA class I antigen presentation is a prerequisite for the recognition of tumor cells by cytotoxic T lymphocytes and thus essential for the success of anticancer immunotherapeutic concepts. Several approaches have been taken in the immunotherapy of metastatic renal cell carcin...

Descripción completa

Detalles Bibliográficos
Autores principales: Stickel, Juliane S, Stickel, Natalie, Hennenlotter, Jörg, Klingel, Karin, Stenzl, Arnulf, Rammensee, Hans-Georg, Stevanović, Stefan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037347/
https://www.ncbi.nlm.nih.gov/pubmed/21251276
http://dx.doi.org/10.1186/1471-2490-11-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037347/
https://www.ncbi.nlm.nih.gov/pubmed/21251276
http://dx.doi.org/10.1186/1471-2490-11-1

Ejemplares similares